JPRN-UMIN000006336已完成未知
Assessment of Response to Thienopyridine in Japanese Population (ART-JP) - ART-JP
Keio University, School of Medicine, Research Park 5S90 个研究点目标入组 300 人开始时间: 2011年9月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients without consent 2) AST > or = 3 x upper limit or ALT > or = 3 x upper 3) Hb < 10 g/dl or platelet < 100k 4) drug allergy to thienopyridine 5) patients with malignancy under treatment or planning to start treatment within one year 6) primary physician thinks it is inappropriate to enroll the patient
研究者
相似试验
已完成
2 期
Clinical Trial of Teriparatide in JapanOsteoporosisNCT00191867Eli Lilly and Company160
已完成
不适用
Efficacy and Safety of Nintedanib in Japanese patients with early stage of idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosis (IPF)JPRN-UMIN000038192Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences215
招募中
4 期
JASPER study-switchRheumatoid arthritisJPRN-jRCT1031220112Yamaoka Kunihiro100
招募中
不适用
Examination of the efficacy of Peficitinib reduction in RA patients in sustained remissioM0690Rheumatoid arthritisJPRN-jRCTs051220027Hashimoto Motomu60
进行中（未招募）
2 期
Phase II clinical study of TR-012001 in Japanese patients with Parkinson's diseaseParkinson's diseaseJPRN-jRCT2061230065Kanazashi Shuichi12